Subscribe To
Renault strikes battery deal with verkor for premium evs
PARIS (Reuters) – Renault on Thursday announced a long-term commercial partnership with French start-up Verkor for the supply of electric batteries ...
April 13, 2023, 6:46 am
Zimvie to report first quarter 2023 financial results on may 3, 2023
WESTMINSTER, Colo., April 12, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and s...
April 12, 2023, 4:10 pm
Gold price outlook remains bullish despite short-term choppiness
While a choppy trading environment is expected in the short term, gold's aggressive rally since March supports a positive long-term outlook....
April 11, 2023, 4:07 pm
At&t: sell before the market rolls over
We recently opined that AT&T would be a sell on the next pop and the market gave us that opportunity to...
April 8, 2023, 3:38 am
Time to buy these alternative energy stocks?
Considering that a majority of alternative energy companies are still in the beginning stages of probability the rising earnings estimates are a great...
April 4, 2023, 3:57 pm
Alpine income property trust: stable return play until next bull market
pine's share price development since early 2022 has outperformed the broader REIT market by 15% implyin...
April 2, 2023, 10:20 am
Philippines, u.s. hold live-fire exercises focused on territorial defence
By Adrian Portugal FORT MAGSAYSAY, Philippines (Reuters) – Philip...
March 31, 2023, 10:15 am
French pension standoff causing cracks in macron’s camp, insiders say
By Elizabeth pineau PARIS (Reuters) – President Emmanuel Macron’s drive to ram through legislation ...
March 31, 2023, 5:59 am
Philippine central bank: march annual inflation likely in 7.4%-8.2% range
MANILA (Reuters) – Philippine annual inflation in March was expected to come in between 7.4% and 8.2%...
March 31, 2023, 3:30 am
Emerging markets-asian fx, equities subdued as focus returns to global policy tightening
Thai baht, Philippine peso inch lower * Equities dampened, Indonesian benchmark down 0.2% * Focus on U....
March 30, 2023, 9:14 pm
Alpine immune: rebuilding itself from scratch, but long way to go before proof
Last year, ALPN ditched its lead program after a second patient death in a CD28 molecule, a previously notorious pathway. ALPN has started all over ag...
March 29, 2023, 7:37 am
Simmons first national corporation announces first quarter 2023 earnings release date and conference call
pine BLUFF, Ark. , March 28, 2023 /PRNewswire/ -- Simmons First National Corporation (NASDAQ: SFNC) tod...
March 28, 2023, 4:30 pm
Why shares of harmony bioscience are slumping tuesday
Harmony has only one approved therapy, Wakix, to treat excessive daytime sleepiness. The drug was respo...
March 28, 2023, 2:17 pm
Alpine income property trust announces first quarter 2023 earnings release and conference call information
WINTER PARK, Fla., March 27, 2023 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: ...
March 27, 2023, 4:10 pm
Joann inc. (joan) q4 2023 earnings call transcript
JOANN Inc. (JOAN) Q4 2023 Earnings Conference Call March 23, 2023 5:00 PM ET Corporate Participants Dan Callahan - ICR Wade Miquelon - President and C...
March 23, 2023, 10:35 pm
Alpine immune sciences, inc. (alpn) q4 2022 earnings call transcript
Alpine Immune Sciences, Inc. (NASDAQ:ALPN ) Q4 2022 Earnings Conference Call March 23, 2023 4:30 PM ET ...
March 23, 2023, 7:41 pm
Alpine immune sciences, inc. (alpn) reports q4 loss, lags revenue estimates
Alpine Immune Sciences, Inc. (ALPN) delivered earnings and revenue surprises of -51.85% and 73.36%, res...
March 23, 2023, 7:03 pm
Gulf keystone petroleum limited (gukyf) q4 2022 earnings call transcript
Gulf Keystone Petroleum Limited (OTCPK:GUKYF) Q4 2022 Earnings Conference Call March 23, 2023 6:00 AM ET Company Participants Jon Harris - CEO Ian Wea...
March 23, 2023, 9:41 am
Monday.com: guidance will be revised upward
monday.com has been a very choppy stock of late. But share price choppiness aside, the business has sol...
March 21, 2023, 2:40 pm
Alpine immune sciences to present povetacicept (alpn-303) phase 1 (ruby-1) study data and clinical pharmacokinetic & pharmacodynamic modeling at upcoming scientific conferences
SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunot...
March 20, 2023, 4:30 pm